EP1079764A4 - The treatment of sexual dysfunction in certain patient groups - Google Patents

The treatment of sexual dysfunction in certain patient groups

Info

Publication number
EP1079764A4
EP1079764A4 EP99920266A EP99920266A EP1079764A4 EP 1079764 A4 EP1079764 A4 EP 1079764A4 EP 99920266 A EP99920266 A EP 99920266A EP 99920266 A EP99920266 A EP 99920266A EP 1079764 A4 EP1079764 A4 EP 1079764A4
Authority
EP
European Patent Office
Prior art keywords
treatment
sexual dysfunction
patient groups
certain patient
certain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99920266A
Other languages
German (de)
French (fr)
Other versions
EP1079764A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RT Alamo Ventures I LLC
Original Assignee
RT ALAMO VENTURES Inc
RT ALAMO VENTURES Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/071,457 external-priority patent/US6110489A/en
Priority claimed from US09/166,703 external-priority patent/US6194433B1/en
Priority claimed from US09/175,395 external-priority patent/US6132753A/en
Priority claimed from US09/260,099 external-priority patent/US6132757A/en
Priority claimed from US09/262,715 external-priority patent/US6187790B1/en
Application filed by RT ALAMO VENTURES Inc, RT ALAMO VENTURES Inc filed Critical RT ALAMO VENTURES Inc
Publication of EP1079764A1 publication Critical patent/EP1079764A1/en
Publication of EP1079764A4 publication Critical patent/EP1079764A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
EP99920266A 1998-05-01 1999-04-30 The treatment of sexual dysfunction in certain patient groups Withdrawn EP1079764A4 (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US262715 1981-05-11
US260099 1994-06-15
US09/071,457 US6110489A (en) 1998-05-01 1998-05-01 Use of quinolines and quinolones to treat male erectile dysfunction
US71457 1998-05-01
US09/166,703 US6194433B1 (en) 1998-10-05 1998-10-05 Sexual dysfunction in females
US166703 1998-10-05
US175395 1998-10-19
US09/175,395 US6132753A (en) 1998-05-01 1998-10-19 Treatment of sexual dysfunction in certain patient groups
US09/260,099 US6132757A (en) 1998-05-01 1999-03-02 Treatment of sexual dysfunction in certain patient groups
US09/262,715 US6187790B1 (en) 1999-03-04 1999-03-04 Use of cilostazol for treatment of sexual dysfunction
PCT/US1999/009610 WO1999056666A1 (en) 1998-05-01 1999-04-30 The treatment of sexual dysfunction in certain patient groups

Publications (2)

Publication Number Publication Date
EP1079764A1 EP1079764A1 (en) 2001-03-07
EP1079764A4 true EP1079764A4 (en) 2001-09-12

Family

ID=27535884

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99920266A Withdrawn EP1079764A4 (en) 1998-05-01 1999-04-30 The treatment of sexual dysfunction in certain patient groups

Country Status (7)

Country Link
EP (1) EP1079764A4 (en)
JP (1) JP2002537231A (en)
AU (1) AU3780699A (en)
BR (1) BR9908716A (en)
CA (1) CA2319542C (en)
MX (1) MXPA00010254A (en)
WO (1) WO1999056666A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548490B1 (en) * 1997-10-28 2003-04-15 Vivus, Inc. Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction
US6403597B1 (en) 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US6541487B1 (en) * 1998-05-01 2003-04-01 R.T. Alamo Ventures I, Llc PDE III inhibitors for treating sexual dysfunction
CA2435876A1 (en) * 2001-01-26 2002-08-01 R.T. Alamo Ventures I, Llc The treatment of sexual dysfunction and cardiovascular disease with quinolinone enantiomers
US6767914B2 (en) 2002-03-01 2004-07-27 R.T. Alamo Ventures I, Llc Fluorinated heterocyclic compounds and methods of synthesis
US6727262B2 (en) 2002-03-01 2004-04-27 R.T. Alamo Ventures I, Llc Dichlorinated heterocyclic compounds and methods of synthesis
US7041677B2 (en) 2002-03-01 2006-05-09 R.T. Alamo Ventures I, Llc Use of monochloroflosequinan in the treatment of sexual dysfunction
US6730790B2 (en) 2002-03-01 2004-05-04 R.T. Alamo Ventures I. Llc Chlorinated heterocyclic compounds and methods of synthesis
GB0208704D0 (en) * 2002-04-16 2002-05-29 Futura Medical Dev Ltd Condom
TWI323660B (en) * 2003-02-25 2010-04-21 Otsuka Pharma Co Ltd Pten inhibitor or maxi-k channels opener
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US5270323A (en) * 1990-05-31 1993-12-14 Pfizer Inc. Method of treating impotence
WO1994002144A1 (en) * 1992-07-21 1994-02-03 The Boots Company Plc Use of 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone in the treatment of angina pectoris
WO1994028902A1 (en) * 1993-06-09 1994-12-22 Pfizer Limited Pyrazolopyrimidinones for the treatment of impotence
WO2000007595A1 (en) * 1998-08-03 2000-02-17 Basf Corporation Pyridinones for the treatment of sexual dysfunction

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4117249C2 (en) * 1991-05-27 1998-05-14 Christian Dr Stief Linsidomine used to treat erectile dysfunction

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4801587A (en) * 1987-03-02 1989-01-31 Gene Voss Impotence ointment
US5270323A (en) * 1990-05-31 1993-12-14 Pfizer Inc. Method of treating impotence
WO1994002144A1 (en) * 1992-07-21 1994-02-03 The Boots Company Plc Use of 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone in the treatment of angina pectoris
WO1994028902A1 (en) * 1993-06-09 1994-12-22 Pfizer Limited Pyrazolopyrimidinones for the treatment of impotence
WO2000007595A1 (en) * 1998-08-03 2000-02-17 Basf Corporation Pyridinones for the treatment of sexual dysfunction

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
IKEZONO ET AL: "General pharmacological properties of the new vasodilator flosequinan", ARZNEIMITTEL FORSCHUNG. DRUG RESEARCH,DE,EDITIO CANTOR. AULENDORF, vol. 42II, no. 10, 1992, pages 1200 - 1211, XP002125660, ISSN: 0004-4172 *
See also references of WO9956666A1 *

Also Published As

Publication number Publication date
JP2002537231A (en) 2002-11-05
EP1079764A1 (en) 2001-03-07
WO1999056666A8 (en) 2000-08-10
MXPA00010254A (en) 2002-08-06
BR9908716A (en) 2000-11-21
AU3780699A (en) 1999-11-23
WO1999056666A1 (en) 1999-11-11
CA2319542A1 (en) 1999-11-11
CA2319542C (en) 2005-07-12

Similar Documents

Publication Publication Date Title
EP1143987A4 (en) Natural composition and method for the treatment of sexual dysfunction
HK1040901A1 (en) Treatment of female sexual dysfunction
EP1027057A4 (en) Treatment of female sexual dysfunction
GB9608408D0 (en) Treatment of erectile dysfunction
HUP0401023A3 (en) Use of flibanserin in the treatment of sexual disorders
HK1015280A1 (en) Use of epinastine in the treatment of pain
HRP980222B1 (en) Pyrazolopyrimidinones for the treatment of sexual disfunction
FI972205A0 (en) cGmp-PDE inhibitors in the treatment of erectile dysfunction
GB9824436D0 (en) Methods of treatment
SI1716853T1 (en) Treatment of cancers of the human body using ET743
EP1079764A4 (en) The treatment of sexual dysfunction in certain patient groups
NO982727D0 (en) PGE-containing lyophilized liposomes for use in the treatment of erectile dysfunction
HK1037517A1 (en) Use of apomorphine in the treatment of premature ejaculation
AU5509099A (en) Pyridinones for the treatment of sexual dysfunction
AU4676099A (en) Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
PL362980A1 (en) Treatment of sexual dysfunction
IL129460A0 (en) Use of lofexidine in the treatment of behavioral disorders
HUP0100365A3 (en) Combination therapy for the treatment of aids
AU2002300509A1 (en) The Treatment of Sexual Dysfunction in Certain Patient Groups
HUP0300043A3 (en) Method and composition for the treatment of pain
GB9904252D0 (en) Composition for the treatment of pain
GB0020261D0 (en) Therapeutic treatment
SI1047428T1 (en) Use of morpholinol for the treatment of sexual dysfunction
GB9603657D0 (en) Improvements in the treatment of vaginal infections
ID28817A (en) USE OF TETRAHIDROPIRIDIN (OR 4-HIDROPIPERIDIN) -BUTILAZOL DRUGS IN THE MAKING OF DRUGS FOR PAIN TREATMENT

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20000801

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20010726

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61F 2/02 A, 7A 61F 13/02 B, 7A 61K 9/20 B, 7A 61K 9/48 B, 7A 61K 31/47 B, 7A 61P 15/10 B

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: R.T. ALAMO VENTURES I, LLC

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20061010